Alan S. L. Yu

Has grant

University of Kansas Medical Center
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Structure-Function Studies of Tight Junction Membrane Proteins

Open Date: 2010-09-30

Close Date: 2015-06-30

Grant: Close

Sodium-chloride co-transporter regulation in the kidney

Open Date: 2010-08-01

Close Date: 2011-07-31

Grant: Close

University of Kansas Training Grant in Nephrology

Open Date: 2005-07-01

Close Date: 2017-06-30

Grant: Close

Expression, function and regulation of renal claudins

Open Date: 2002-07-01

Close Date: 2013-05-31

Grant: Close

Kansas Polycystic Kidney Imaging Program

Open Date: 2000-02-01

Close Date: 2016-05-31

Articles (11)

Claudin-2 is a tight junction protein expressed in leaky epithelia where it forms paracellular pores permeable to cations and water. The paracellular pore formed by claudin-2 is important in energy-efficient cation and water transport in the proximal tubules of the kidneys. Mounting evidence now suggests that claudin-2 may modulate cellular processes often altered in disease, including cellular proliferation. Also, dysregulation of claudin-2 expression has been linked to various diseases, including kidney stone disease and renal cell carcinoma. However, the mechanisms linking altered claudin-2 expression and function to disease are poorly understood and require further investigation. The aim of this review is to discuss the current understanding of the role of claudin-2 in kidney function and dysfunction. We provide a general overview of the claudins and their organization in the tight junction, the expression, and function of claudin-2 in the kidney, and the evolving evidence for its role in kidney disease.

Year:

2023

To our knowledge, this study is the first to generate urinary global metabolomic profiles from individuals with early-stage ADPKD with preserved renal function for biomarker discovery. The exploratory dataset reveals metabolic pathway alterations that may be responsible for early cystogenesis and rapid disease progression and may be potential therapeutic targets and pathway sources for candidate biomarkers. From these results, we generated a panel of candidate diagnostic and prognostic biomarkers of early-stage ADPKD for future validation.

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

Ronald K. June

Montana State University

UNITED STATES
View details

Ronald D. Perrone

Tufts University School of Medicine

UNITED STATES
View details

Mei Liu

Associate Professor

University of Florida

UNITED STATES
View details

Gunda Georg

Regents Professor and Department Head

University of Minnesota System

UNITED STATES
View details

Michael Matheny

Associate Professor

Vanderbilt University Medical Center

UNITED STATES
View details

Alyssa K. Hahn

-

UNITED STATES
View details

Xing Song

Assistant Professor

University of Missouri

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.